+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America E. coli Testing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology; End User, and Country

  • ID: 5130886
  • Report
  • July 2020
  • Region: North America
  • 125 Pages
  • The Insight Partners
UP TO OFF until Jun 30th 2022

FEATURED COMPANIES

  • Abbott (Alere Inc.)
  • BD
  • Bio-Rad Laboratories, Inc
  • Hologic, Inc
  • IDEXX Laboratories, Inc.
  • Meridian Bioscience, Inc.
The North America E. coli testing market is expected to reach US$ 1,165.0 million by 2027 from US$ 680.9 Mn in 2019. The market is estimated to grow at a CAGR of 7.1% during 2020-2027. The E. coli testing market is growing primarily due to the rise in E. coli testing, growing product innovation, and rising research activities in the North America region. However, the challenges in the E. coli testing damage the growth of the market. Additionally, increasing adoption of multiplex PCR technology and developments in biotechnology sector are likely to fuel the growth of the E. coli testing market during the forecast period.

Escherichia coli (E. coli) are rod-shaped gram-negative bacteria that are generally available in the food, environment, and intestines of warm-blooded animals. The majority of the E. coli strains are typically harmless to humans. Still, some strains are recognized to be the reason for serious some medical complications such as gastrointestinal tract infections, cholecystitis, cholangitis, neonatal meningitis, bacteremia, pneumonia, urinary tract infection (UTI) and regularly spread via polluted food or water.

The majority of instances of food poisoning and infectious diseases is caused due to E. coli. Therefore, it is essential to detect the concentration E. coli in various products. Apart from industrial sectors such as pharmaceutical, biotechnology, and environmental, the food & beverages sector is at a higher risk of E coli contamination. It is imperative for food & beverage companies to detect and monitor the presence of the bacteria before starting production, during the production process, and in the final products.

Similarly, various pharmaceutical and biotechnology companies follow good manufacturing practices (GMP), and current good manufacturing practices (cGMP). Rising incidences of infectious diseases are also leading to the diagnosis of E. coli in the samples collected from the patients. On average, adults in the United States have acute diarrhea once a year. Young children have it an average of twice a year. According to recent reports by the CDC, there were 11 multistate outbreaks of Shiga toxin-producing E. coli in the USA from 2011 to 2014 with six of them attributed to E. coli. Therefore, E. coli testing is widely performed across various countries, in turn, driving its market growth.

The outbreak of the COVID-19 pandemic has highly affected the North American region. The outbreak of pandemic has affected the E. coli testing market across the region. At present, the majority of the diagnostic laboratories and research institutes and centers are involved in diagnosing the COVID-19 and vaccines to treat the deadly virus. Thus, the shift of research centers and diagnostics laboratories towards the COVID19 pandemic has hindered the market growth. However, it is expected that the impact of the pandemic is likely to be seen for a few years. Also, the presence of various diagnostics and clinical laboratories offering E. coli testing is expected to contribute greatly during the forecast period.

In 2019, the monoclonal antibodies segment accounted for the largest share of the E. coli testing market. Monoclonal antibodies offer advantages such as low cross-reactivity, high specificity, and excellent lot-to-lot stability, which are likely to contribute to the dominancy of the segment during the forecast period.

A few of the significant secondary sources associated with the North America E. coli testing market report include World Health Organization (WHO), Centers of Disease Control and Prevention (CDC), OECD Health Statistics, and others.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America E. coli Testing Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America E. coli Testing Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott (Alere Inc.)
  • BD
  • Bio-Rad Laboratories, Inc
  • Hologic, Inc
  • IDEXX Laboratories, Inc.
  • Meridian Bioscience, Inc.

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 North America E. coli Testing Market - By Technology
1.3.2 North America E. coli Testing Market - By End-User
1.3.3 North America E. coli Testing Market - By Country
2. North America E. coli Testing Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America E. coli Testing Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 E. coli Testing Market - North America PEST Analysis
4.3 Expert Opinion
5. North America E. coli Testing Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing E. coli Testing
5.1.2 Growing Product Innovations
5.1.3 Rising Research Activities
5.2 Key Market Restraints
5.2.1 Testing Challenges
5.3 Key Market Opportunities
5.3.1 Increasing Adoption of Multiplex PCR Technology
5.4 Future Trends
5.4.1 Developments in Biotechnology
5.5 Impact Analysis
6. E. coli Testing Market - North America Analysis
6.1 North America E. coli Testing Market Revenue Forecasts and Analysis
7. North America E. coli Testing Market Analysis - By Technology
7.1 Overview
7.2 North America E. coli Testing Market, By Technology 2019-2027 (%)
7.2.1 North America E. coli testing Market Devices Revenue and Forecasts to 2027, By Technology (US$ Mn)
7.3 Monoclonal Antibodies
7.3.1 Overview
7.3.2 North America Monoclonal Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Differential Light Scattering
7.4.1 Overview
7.4.2 North America Differential Light Scattering Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Molecular Diagnostics
7.5.1 Overview
7.5.2 North America Molecular Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Immunoassays
7.6.1 Overview
7.6.2 North America Immunoassays Market Revenue and Forecasts to 2027 (US$ Mn)
7.7 Chromatography
7.7.1 Overview
7.7.2 North America Chromatography Market Revenue and Forecasts to 2027 (US$ Mn)
7.8 Flow Cytometry
7.8.1 Overview
7.8.2 North America Flow Cytometry Market Revenue and Forecasts to 2027 (US$ Mn)
7.9 Gel Microdroplets
7.9.1 Overview
7.9.2 North America Gel Microdroplets Market Revenue and Forecasts to 2027 (US$ Mn)
7.10 Diagnostic Imaging
7.10.1 Overview
7.10.2 North America Diagnostic Imaging Market Revenue and Forecasts to 2027 (US$ Mn)
8. North America E. coli Testing Market Analysis - By End-User
8.1 Overview
8.2 North America E. coli Testing Market, By Application 2019-2027 (%)
8.2.1 North America E. coli Testing Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
8.3 Commercial or Private Labs
8.3.1 Overview
8.3.2 North America Commercial or Private Labs Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Physician Offices
8.4.1 Overview
8.4.2 North America Physician Offices Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Hospitals
8.5.1 Overview
8.5.2 North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Public Health Labs
8.6.1 Overview
8.6.2 North America Public Health Labs Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Academic Research Institutes
8.7.1 Overview
8.7.2 North America Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
9. E. coli Testing Market Revenue and Forecasts To 2027 - Geographical Analysis
9.1 North America E. coli Testing Market Revenue and Forecasts To 2027
9.1.1 Overview
9.1.2 North America: E. coli Testing Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: E. coli Testing Market, by Technology, 2018-2027 (USD Million)
9.1.4 North America: E. coli Testing Market, by End User , 2018-2027 (USD Million)
9.1.5 North America: E. coli Testing Market, by Country, 2019 & 2027 (%)
9.1.6 US: E. coli Testing Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: E. coli Testing Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: E. coli Testing Market, by Technology, 2018-2027 (USD Million)
9.1.6.3 US: E. coli Testing Market, by End User , 2018-2027 (USD Million)
9.1.7 Canada: E. coli Testing Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: E. coli Testing Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: E. coli Testing Market, by Technology, 2018-2027 (USD Million)
9.1.7.3 Canada: E. coli Testing Market, by End User , 2018-2027 (USD Million)
9.1.8 Mexico: E. coli Testing Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: E. coli Testing Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: E. coli Testing Market, by Technology, 2018-2027 (USD Million)
9.1.8.3 Mexico: E. coli Testing Market, by End User , 2018-2027 (USD Million)
10. Impact Of COVID-19 Pandemic on North America E. coli Testing Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. COMPANY PROFILES
11.1 BIO-RAD LABORATORIES INC.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Pro Lab Diagnostics Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Abbott
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 IDEXX LABORATORIES, INC.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 MERIDIAN BIOSCIENCE, INC.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 BD
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Thermo Fisher Scientific INC.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 NEOGEN Corporation
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Hologic, Inc.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 Glossary of Terms
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Bio-Rad Laboratories, Inc
  • Pro-Lab Diagnostics, Inc.
  • Abbott (Alere Inc.)
  • IDEXX Laboratories, Inc.
  • Meridian Bioscience, Inc.
  • BD
  • Thermo Fisher Scientific, Inc.
  • NEOGEN Corporation
  • Hologic, Inc
Note: Product cover images may vary from those shown